Young people are disproportionately affected by hepatitis and HIV, yet many remain unaware of it due to a lack of accessible, youth-friendly information. Many young people are coinfected with HIV and hepatitis but don’t know it, as they share common transmission routes, such as unprotected sex and injection drug use. To bridge this gap, Y+ Global and the World Hepatitis Alliance collaborated to create a digital toolkit, “Living Positively with HIV and Hepatitis”, to offer clear, easy-to-understand information about HIV and hepatitis.
This toolkit, launched at AIDS 2024, was introduced to a global audience with the key focus of dispelling myths and empowering individuals to make informed health decisions. It offers comprehensive information on HIV and hepatitis, including transmission methods, symptoms, testing and the misconceptions surrounding both diseases. Additionally, the toolkit guides how to live positively with hepatitis and HIV, emphasising the importance of education and proactive health care.
To strengthen our advocacy efforts, Y+ Global and the World Hepatitis Alliance will be conducting a survey to gather insights from young people living with HIV and hepatitis. The purpose of this survey is to gain further understanding of shared experiences so that together, we can develop and share case studies of young people living with HIV and hepatitis. By collecting personal stories from young people, we aim to shed light on their unique challenges and showcase the work being led by young people. Additionally, if your organisation is aware of initiatives addressing youth and co-infections, we would like to hear from you!
About Y+ Global and the World Hepatitis Alliance
The Global Network of Young People Living with HIV (Y+ Global) is the largest network of young people living with HIV, collaborating with over 120 implementing partners across 41 countries. Meanwhile, the World Hepatitis Alliance (WHA) is an international network of over 340 civil society and community organisations in over 100 countries, working towards eliminating hepatitis by 2030. Together, we represent powerful global efforts to address the intersecting challenges of HIV and hepatitis.